Although the FDA approved OTC naloxone to facilitate access, sales peaked in the first month it was available before quickly decreasing. The number of OTC units sold per million residents was much ...
Here are the top 5 stories from 2025 about the advancements in prostate, kidney, and bladder cancers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback